Senior Scientist/ VP Research

Targovax is a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors. Targovax aims to unlock greater clinical benefits in cancer patients by deploying its multifunctional platforms to target key immune regulators and oncogenic drivers. Targovax’s focus is to “activate the patient’s immune system to fight cancer”, thus extending and transforming the lives of cancer patients. Targovax’s pipeline aims at different cancer indications, including melanoma, mesothelioma and colorectal cancer.

Targovax’s lead clinical candidate, ONCOS-102, is a genetically modified oncolytic adenovirus, which has been engineered to selectively infect cancer cells and activate the immune system to fight the cancer. Targovax has employees located both in Oslo, Norway and Espoo, Finland.

For more information about the company, please visit: www.targovax.com

Targovax is currently seeking an accomplished Senior Scientist/ VP Research to join the R&D Department of Targovax and drive the company’s preclinical research programs.

Responsibilities

  • Develop and drive the company´s pre-clinical experimental research strategy
  • Plan and manage execution of pre-clinical experiments
  • Analyze, synthesize, and present preclinical and clinical data sets in written and visual form
  • Lead preparation of non-clinical sections of Regulatory documents (IND, CTA, Briefing materials)
  • Manage contacts with external partners, CROs, academic collaborators
  • Attend partner meetings and give scientific presentations
  • Collaborate with other departments, particularly clinical and business development

Qualifications

The ideal candidate should have the following education and experience:

  • PhD in molecular biology, ideally immunology or cancer biology
  • At least 3 to 5 years’ experience of working on research or translational projects in oncology/immuno-oncology/biologics. Candidates with experience of working at small or midsize biotech companies are preferred
  • Demonstrated ability to set up, coordinate and execute complex research projects, including in vitro and in vivo experiments in the field of oncology
  • Up to date knowledge of and experience in relevant immunological, molecular and cell biology experimental techniques, as well as in vivo models
  • Experience in working with viruses would be an advantage
  • Solid publication record, preferably in immuno-oncology
  • Experience of interactions and work-package planning with pre-clinical CROs
  • Knowledge of ICH-GCP
  • Experience from interactions with Regulatory Agencies
  • Ability to work independently and drive teamwork
  • Ability to succinctly present data in written and visual format, including giving oral presentations
  • Fluent written and spoken English

Style

  • Strategic thinker, merging science with business priorities
  • Thrive in team-based problem-solving situations
  • Results-oriented
  • Ambitious
  • Curious mindset

Ideally the Senior Scientist/VP Research should be based in Stockholm, Oslo or Helsinki, but other locations may be accommodated for the right candidate. Frequent travel to Oslo and Helsinki will be required.
We can offer varied and exciting work in an innovative and dynamic biotech company. We promise you will develop professionally with challenging tasks in a growing company, as you participate in the development of novel cancer treatments. If you are not already familiar with the biotech industry, we can guarantee a steep learning curve while you experience an informal and supportive company culture.

Please send your CV and cover letter in English to renate.birkeli@targovax.com as soon as possible.
For additional information please contact Renate Birkeli via e-mail as above or phone: +47 92261624. All applications will be treated confidentially